<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Initial treatment of active antibody-mediated rejection of the kidney allograft</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Initial treatment of active antibody-mediated rejection of the kidney allograft</h1>
<div class="graphic"><div class="figure"><div class="ttl">Initial treatment of active antibody-mediated rejection of the kidney allograft</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">The optimal treatment of active antibody-mediated rejection is unknown, and protocols vary between centers. The approach shown in this algorithm is based upon the authors' clinical experience and is consistent with protocols in use at some major centers.</div><div class="graphic_footnotes"><p>ABMR: antibody-mediated rejection; 
		IVIG: intravenous immune globulin.</p>
<p>* Treatment of mixed acute rejection involves treatment of both antibody-mediated rejection and T cell-mediated rejection. Refer to UpToDate content on the treatment of acute T cell-mediated rejection.</p>
<p>¶ Refer to UpToDate content on dosing and administration of pulse glucocorticoids for the treatment of ABMR of the kidney allograft.</p>
<p>Δ All patients who are treated for active ABMR should reinitiate antimicrobial and antiviral prophylaxis with a regimen that is identical to that administered in the immediate posttransplant period. This includes prophylaxis against <em>Pneumocystis</em> pneumonia (PCP), cytomegalovirus (CMV) infection and disease, and herpes simplex infection (in patients who are at low CMV risk) for three months. We also administer antifungal prophylaxis and a prophylactic histamine-2 (H2) blocker for prevention of peptic ulcer disease, although this practice may vary by center. Refer to UpToDate topics for specific regimen details.</p>
<p>◊ Refer to UpToDate content on dosing and administration of plasmapheresis and IVIG for treatment of ABMR of the kidney allograft.</p>
<p>§ Some experts administer rituximab if the patient is younger (eg, age &lt;70 years), has better allograft function (eg, estimated glomerular filtration rate [eGFR] ≥20 mL/min/1.73 m<sup>2</sup> and lower chronicity scores on biopsy [ie, interstitial fibrosis + tubular atrophy + fibrous intimal thickening + allograft glomerulopathy &lt;8]), and has evidence of severe disease (eg, higher donor-specific antibody [DSA], diffuse C4d staining, or more extensive microvascular inflammation [ie, glomerulitis score + peritubular capillary score ≥4]) on biopsy.</p>
<p>¥ Refer to UpToDate content on the augmentation of maintenance immunosuppression in kidney transplant recipients with acute rejection.</p>
	
	‡ In patients who are &gt;1 year posttransplant, plasmapheresis is not performed due to the lack of evidence supporting its safety and efficacy in late-onset ABMR. However, some transplant centers continue to administer plasmapheresis for ABMR diagnosed after one year posttransplant. Refer to UpToDate content on dosing and administration of IVIG for the treatment of ABMR of the kidney allograft.</div><div id="graphicVersion">Graphic 116370 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
